• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Gefitinib novel inhibtior

Supplementary Materialsijms-19-00158-s001. metabolism and proliferation. Applying the Rho-GDI signaling pathway being

June 18, 2019 by Katherine Lewis Leave a Comment

Supplementary Materialsijms-19-00158-s001. metabolism and proliferation. Applying the Rho-GDI signaling pathway being a paradigm, we propose potential biomarkers for SHEDs as well as for PDLSCs, reflecting their particular features, Gefitinib novel inhibtior properties and involved molecular pathways. (((((((or (((( 0.05) from the commonly identified protein for both SHEDs and PDLSCs (Figure 1A) revealed that a lot … [Read more…]

Posted in: Blogging Tagged: Gefitinib novel inhibtior, Rabbit polyclonal to AP4E1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by